Targeted drug delivery nanosystems based on copolymer poly(lactide)-tocopheryl polyethylene glycol succinate for cancer treatment

• Published in: Advances in natural sciences. Nanoscience and nanotechnology Vol. 7; no. 1; p. 015001
• Main Authors: Ha, Phuong Thu, Nguyen, Hoai Nam, Do, Hai Doan, Phan, Quoc Thong, Thi, Minh Nguyet Tran, Nguyen, Xuan Phuc, Thi, My Nhung Hoang, Le, Mai Huong, Nguyen, Linh Toan, Bui, Thuc Quang, Phan, Van Hieu
• Format: Journal Article
• Language: English
• Published: IOP Publishing 01.03.2016
• Subjects: Cancer; Copolymers; Drug delivery systems; Drugs; folate; Nanoparticles; Nanostructure; Nanotechnology; PLA-TPGS nanoparticles; Polyethylene glycol; targeted delivery
• ISSN: 2043-6262; 2043-6254; 2043-6254; 2043-6262
• DOI: 10.1088/2043-6262/7/1/015001

Along with the development of nanotechnology, drug delivery nanosystems (DDNSs) have attracted a great deal of concern among scientists over the world, especially in cancer treatment. DDNSs not only improve water solubility of anticancer drugs but also increase therapeutic efficacy and minimize the side effects of treatment methods through targeting mechanisms including passive and active targeting. Passive targeting is based on the nano-size of drug delivery systems while active targeting is based on the specific bindings between targeting ligands attached on the drug delivery systems and the unique receptors on the cancer cell surface. In this article we present some of our results in the synthesis and testing of DDNSs prepared from copolymer poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS), which carry anticancer drugs including curcumin, paclitaxel and doxorubicin. In order to increase the targeting effect to cancer cells, active targeting ligand folate was attached to the DDNSs. The results showed copolymer PLA-TPGS to be an excellent carrier for loading hydrophobic drugs (curcumin and paclitaxel). The fabricated DDNSs had a very small size (50-100 nm) and enhanced the cellular uptake and cytotoxicity of drugs. Most notably, folate-decorated paclitaxel-loaded copolymer PLA-TPGS nanoparticles (Fol/PTX/PLA-TPGS NPs) were tested on tumor-bearing nude mice. During the treatment time, Fol/PTX/PLA-TPGS NPs always exhibited the best tumor growth inhibition compared to free paclitaxel and paclitaxel-loaded copolymer PLA-TPGS nanoparticles. All results evidenced the promising potential of copolymer PLA-TPGS in fabricating targeted DDNSs for cancer treatment.